Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy - Wikidata - awgldk - TriplyDB

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy

http://www.wikidata.org/entity/Q36184151

about

Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study.Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individuals.Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions.A case of bronchiolitis obliterans organizing pneumonia in an HIV-infected Korean patient successfully treated with clarithromycin.Colonization by Pneumocystis jirovecii and its role in disease.Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status.Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.Clinical and translational research in pneumocystis and pneumocystis pneumonia.Clinical review: Respiratory failure in HIV-infected patients--a changing picture.It gets better: resolution of internalized homophobia over time and associations with positive health outcomes among MSM.Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.Respiratory infection complicating HIV infection Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury.Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic, fungal pathogen.Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia.An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases.The changing epidemiology of HIV-infected patients in the intensive care unit.The trophic life cycle stage of the opportunistic fungal pathogen Pneumocystis murina hinders the ability of dendritic cells to stimulate CD4(+) T cell responses.Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.Epidemiology and Outcomes in Critically Ill Patients with Human Immunodeficiency Virus Infection in the Era of Combination Antiretroviral Therapy.The ART of caring for patients with HIV infection in the ICU Survival after Pneumocystis jirovecii pneumonia requiring ventilation: A case report.Outcomes of HIV-associated pneumocystis pneumonia at a South African referral hospital A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumonia Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy Seasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patients Echinocandins for pneumonia in non-HIV patients: A case report

P2860

Q33369974-C6F28761-8F53-42F7-8F52-05B652AC0D93 Q33592578-3290BA3E-A76F-4E64-A41A-39F35C37EB64 Q34250648-302255E5-34B0-4AE4-981E-E3E60A2B5610 Q34718247-280895D2-2A82-47E7-9095-B6AFBACD111A Q35095045-CFF18F1D-3F44-4138-B29D-8A4FA297E5E4 Q35557252-BBC2E3BD-F834-4564-86C7-85B80F178873 Q35706053-50519E0D-2ADC-4A22-BE25-4551328DF402 Q35940586-885564FF-32B5-4EF3-81D1-85D42894F790 Q36225459-6775BFD9-807D-456D-8CE1-9CF557BF055C Q36300347-B77A3395-A2DE-44AA-802C-21C2B1BAE464 Q36570827-BEC9D6A0-CAAE-4A6D-87BD-BA3FCFA55B7B Q36642119-AE23E3B2-4141-43AF-B22C-AF7767EACCBB Q36899081-360B029C-C0E1-420A-AD8E-D46B5B6055C0 Q36998358-2BBAB7F9-2FC0-4BB3-AFA7-A1D112044FE2 Q37003522-E8DFEE5F-BC00-4D34-8453-BF08F68C3133 Q37055188-4F0F3D7D-A99A-4193-A7EF-5861C56E2434 Q37085842-5D6F9F44-9BFD-42DE-AAF7-6F69A72F617C Q37179389-A191A08C-E766-4C9D-9A33-78AF104B2E61 Q37342714-0615E1F4-4C05-44CC-9D34-A5B76B385B64 Q37345920-9B4FC227-4A3D-4C27-A1E9-D3FF6843C683 Q37457246-E430539C-3748-4818-BF96-A256DCEEF6BF Q37727733-73D015A4-B95B-42F7-A57B-A5653F211679 Q37848593-9F9F8564-B3D8-4B19-87D4-1A9F23DA2EF3 Q37857545-24CE5A6C-6B89-46F1-8286-2DABEB28B35D Q38685422-37942978-46F3-4291-B5D1-258FF1D874AF Q40092648-C5251F18-74AA-47AB-AD38-C6FFBB7DE68C Q40271126-1E60D3E5-E367-4561-ADE0-51A818430085 Q42562627-BF1950BF-EE3F-45C9-9DA1-3CE8D6CFF671 Q53747576-D7BA1189-CD3F-4D92-87DC-D860BBE1529D Q56956015-78459B1D-1605-40A8-880B-9E7C75B98FDA Q57586333-06E812AD-5C80-4AF7-9EC2-0449ACC9FEDC Q57586341-A6B384E8-9AD0-4283-B393-9DB70FF427E5 Q57586379-6DCC3B46-BDFF-4B79-837E-D3BEF2453388 Q58796651-6352E456-F067-4F21-896C-2A7EB6B1B154

P2860

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy

http://www.wikidata.org/entity/Q36184151

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Improved survival for HIV infe ...... active antiretroviral therapy

@ast

Improved survival for HIV infe ...... active antiretroviral therapy

@en

type

label

Improved survival for HIV infe ...... active antiretroviral therapy

@ast

Improved survival for HIV infe ...... active antiretroviral therapy

@en

prefLabel

Improved survival for HIV infe ...... active antiretroviral therapy

@ast

Improved survival for HIV infe ...... active antiretroviral therapy

@en

P1433

Q36184151-E2B11DEA-FC43-4D3F-8DFC-A7056E5EB046

P1476

Q36184151-1667EBB4-9D2C-4632-BBF7-45D47056BCC6

P2093

Q36184151-14D43AB6-93F0-4329-AC82-17CFDEBC621D

Q36184151-2B98C2C9-2839-4FAD-85B7-EFDDDA9DF2EC

Q36184151-6753F0F0-467A-42FE-847C-D1356CB415A1

Q36184151-8DBBCF48-BE7D-46CC-BADF-5512BDE5B11C

P2860

Q36184151-00EF32DE-9155-4BC9-8E06-06BEBD6C24B3

Q36184151-081C0D8B-8CB5-49F9-B483-CB5AAE881B2F

Q36184151-0CBE5920-6EC8-4435-8671-15192A6F6E5C

Q36184151-0E59792E-C843-46A1-B010-1064D794417E

Q36184151-0E8A775F-A975-4AC8-B850-E02E74B8807C

Q36184151-103D4991-73FD-4295-8013-CFA114C6B1A9

Q36184151-184F616F-B1A5-4CA6-A102-3E7E5DB17E71

Q36184151-2082804C-833C-4990-A9A0-E5C6E839581D

Q36184151-2F570EB0-0704-41FD-96E4-76B4AF3D137A

Q36184151-30EB1E7A-CC05-4050-AAFB-8474A2AFE03D

P304

Q36184151-4BE39C29-9B88-42CB-A80E-2CD981811517

P31

Q36184151-C924D332-9309-431A-9C2D-78E979371F25

P356

Q36184151-E874A0A9-9CB2-4371-BB2C-F646D1DAC8AE

P407

Q36184151-D2C80923-565A-452B-9FEC-B020A633E032

P433

Q36184151-B36CCE5A-6219-4A52-B604-ECA8071861D1

P478

Q36184151-17C99F25-4B86-4BD4-B70C-2F679F701E2A

P50

Q36184151-D6744060-C469-401F-A0D8-64285C545639

P577

Q36184151-EAA7A6DF-1A3D-4F56-BAFA-F28C2478B4FB

P5875

Q36184151-A16EC801-E7B2-4407-B4F2-12631613E9D5

P698

Q36184151-E4C28596-E7C5-4799-88A7-808477959E57

P921

Q36184151-92394A73-B466-45FE-B23F-A0E2D222C1DC

Q36184151-BE04B8FA-2D72-4FAB-916B-98965C35E463

P932

Q36184151-375D54B0-0C1C-400F-8B9A-36D638490DFF

P356

THX.2005.055905

P1433

P1476

Improved survival for HIV infe ...... active antiretroviral therapy

@en

P2093

E Allen

http://www.w3.org/2001/XMLSchema#string

M Singer

http://www.w3.org/2001/XMLSchema#string

R F Miller

http://www.w3.org/2001/XMLSchema#string

S G Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome

Current epidemiology of Pneumocystis pneumonia

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

APACHE II: a severity of disease classification system

Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia.

Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia.

Serum lactic dehydrogenase predicts mortality in patients with AIDS and Pneumocystis pneumonia.

Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia.

Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia.

Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

P304

716-721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2005.055905

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7178894

http://www.w3.org/2001/XMLSchema#string

P698

16601092

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2104703

http://www.w3.org/2001/XMLSchema#string